Los programas del fabricante
No encontramos un programa de ahorro de PursueCare para reSET-O en su sitio web. Lo revisamos por última vez el 16 de noviembre de 2026.
Más formas de pagar menos
- Pregunte a su aseguradora qué parte de su plan lo cubre: el beneficio de farmacia o el de equipo médico. Lo que usted paga puede ser distinto en cada uno.
- La tarjeta de ahorro de un fabricante por lo general no se puede usar con Medicare, Medicaid, TRICARE ni la cobertura del VA. Esos planes tienen sus propias reglas para los dispositivos.
- El dinero de una cuenta de ahorros para la salud (HSA) o de una cuenta de gastos flexibles (FSA) por lo general sirve para pagar un dispositivo médico.
- Compárelo con los dispositivos similares de abajo: los programas de cada fabricante son distintos.
Qué es
Una aplicación móvil con receta (Android o iOS) que ofrece terapia cognitivo-conductual junto con el tratamiento ambulatorio.
En palabras de los registros de la FDA (en inglés)
Mental health/function therapeutic software, screen-viewed. A screen-based (non-virtual-reality) software program intended to be used with an off-the-shelf computer/smart device to help improve mental health/wellbeing (e.g., control effects of mood disorders, stress) and/or a cognitive function (e.g., concentration, memory, eye movement training to improve reading, speech) by providing a patient with on-screen interactive sessions. It may additionally be designed to assess cognition/mental health, set baselines, help manage pain, and will typically track development (i.e., interactive). It is not intended for kinesiology-based neuromuscular rehabilitation. It is intended to be used by the patient and may involve clinical assistance/recommendations.
Computerized Behavioral Therapy Device For Substance Use Disorders. The device is intended to provide cognitive behavioral therapy to treat substance use disorder.
Solo su médico puede decirle si un dispositivo es adecuado para usted.
En la base de datos de dispositivos de la FDA
- Necesita receta.
- Empresa en sus registros de la FDA: Pear Therapeutics.
20 versiones a la venta
Cada una abre su registro de la FDA (en inglés). El número de modelo está en la caja.
- PursueCare RESET RESET Mobile Application runs on Andriod and is intended to provide cognitive behavioral therapy, as an adjunct to a contingency management system, for patients 18 years of age and older. Modelo 2.0.2
- PursueCare RESET RESET Mobile Application runs on iOS and is intended to provide cognitive behavioral therapy, as an adjunct to a contingency management system, for patients 18 years of age and older. Modelo 2.0.2
- PursueCare RESET-O RESET-O is an Android application intended to increase retention of opioid use disorder patients in outpatient treatment by providing cognitive behavioral therapy as a adjunct to outpatient treatment. Modelo 2.0.2
Mostrar las 20
- PursueCare RESET-O RESET-O is an iOS application intended to increase retention of opioid use disorder patients in outpatient treatment by providing cognitive behavioral therapy as an adjunct to outpatient treatment. Modelo 2.0.2
- reSET reSET is intended to provide cognitive behavioral therapy, as an adjunct to a contingency management system, for patients 18 years of age and older who are currently enrolled in outpatient treatment under the supervision of a clinician. reSET is indicated as a 12 week (90 days) prescription-only tre Modelo 1
- reSET reSET is intended to provide cognitive behavioral therapy, as an adjunct to a contingency management system, for patients 18 years of age and older who are currently enrolled in outpatient treatment under the supervision of a clinician. reSET is indicated as a 12-week (90 days) prescriptiononly trea Modelo 1
- reSET Demo Version reSET is a prescription-only digital therapy intended to deliver cognitive behavioral therapy (CBT) to patients with substance use disorder (SUD). The Demo Version provides demonstration access to various prescription versions of the reSET product and is not intended for patients. Modelo 1
- reSET Demo Version (Mobile App, Android) reSET Mobile Application running on Android. reSET is a prescription-only digital therapy intended to deliver cognitive behavioral therapy (CBT) to patients with substance use disorder (SUD). The Demo Version provides demonstration access to various prescription versions of the reSET product and is Modelo 1
- reSET Demo Version (Mobile App, iOS) reSET Mobile Application running on iOS. reSET is a prescription-only digital therapy intended to deliver cognitive behavioral therapy (CBT) to patients with substance use disorder (SUD). The Demo Version provides demonstration access to various prescription versions of the reSET product and is not Modelo 1
- reSET Mobile App, Android reSET Mobile Application running on Android. reSET is intended to provide cognitive behavioral therapy, as an adjunct to a contingency management system, for patients 18 years of age and older who are currently enrolled in outpatient treatment under the supervision of a clinician. reSET is indicated Modelo 1
- reSET Mobile App, iOS reSET Mobile Application running on iOS. reSET is intended to provide cognitive behavioral therapy, as an adjunct to a contingency management system, for patients 18 years of age and older who are currently enrolled in outpatient treatment under the supervision of a clinician. reSET is indicated as Modelo 1
- reSET Non-Monetary CM reSET is intended to provide cognitive behavioral therapy, as an adjunct to a contingency management system, for patients 18 years of age and older who are currently enrolled in outpatient treatment under the supervision of a clinician. reSET is indicated as a 12-week (90 days) prescriptiononly trea Modelo 1
- reSET-O reSET-O is intended to increase retention of patients with opioid use disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are cu Modelo 1
- reSET-O reSET-O is intended to increase retention of patients with Opioid Use Disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are cu Modelo 1
- reSET-O Demo Version reSET-O is a prescription-only digital therapy intended to deliver cognitive behavioral therapy (CBT) to patients with opioid use disorder (OUD). The Demo Version provides demonstration access to various prescription versions of the reSET-O product and is not intended for patients. Modelo 1
- reSET-O Demo Version (Mobile App, Android) reSET-O Mobile Application running on Android. reSET-O is a prescription-only digital therapy intended to deliver cognitive behavioral therapy (CBT) to patients with opioid use disorder (OUD). The Demo Version provides demonstration access to various prescription versions of the reSET-O product and Modelo 1
- reSET-O Demo Version (Mobile App, iOS) reSET-O Mobile Application running on iOS. reSET-O is a prescription-only digital therapy intended to deliver cognitive behavioral therapy (CBT) to patients with opioid use disorder (OUD). The Demo Version provides demonstration access to various prescription versions of the reSET-O product and is n Modelo 1
- reSET-O Mobile App, Android reSET-O Mobile Application running on Android. reSET-O is intended to increase retention of patients with opioid use disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency manage Modelo 1
- reSET-O Mobile App, iOS reSET-O Mobile Application running on iOS. reSET-O is intended to increase retention of patients with opioid use disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management Modelo 1
- reSET-O Non-Monetary CM reSET-O is intended to increase retention of patients with Opioid Use Disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are cu Modelo 1
Fuente: la base de datos de dispositivos de la FDA (GUDID), 2 de noviembre de 2026.
Dispositivos similares
- EndeavorRx Akili $99 por una receta de 30 días · Para cualquier persona
- Somryst Nox Health No encontramos un programa del fabricante
- Freespira Freespira No encontramos un programa del fabricante
- Luminopia Luminopia Ayuda si califica · Para cualquier persona
- CureSight NovaSight No encontramos un programa del fabricante
- BlueStar Welldoc No encontramos un programa del fabricante
- RelieVRx AppliedVR No encontramos un programa del fabricante
- NightWare NightWare No encontramos un programa del fabricante
Ver los 10: aplicaciones con receta y tratamientos digitales